English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The diagnostic pathway for prostate cancer has changed recently with the introduction of a pre-biopsy MRI. This audit aims to identify whether this change helps the University Hospitals of Morecambe Bay NHS Foundation Trust meet the national standard of referral to treatment time of 62 days. Method This audit will follow the individual journeys of patients on the previous (05/2017 – 05/2018) and new pathway (08/2018 – 04/2019). In addition, they will be divided based on the treatment they chose – surgery or radiotherapy. Results Old pathway: New pathway: Conclusions Comparing the new pathway to the previous, there is a reduced proportion meeting the RTT. One way to combat this is ensuring patients have their MRI scans, if suitable, prior to their first clinic, which shows to be the most effective way to meet the RTT.

722 Review of The Introduction of Pre-Biopsy MRI Scanning in The Diagnostic Pathway for Prostate Cancer